167 related articles for article (PubMed ID: 1362800)
1. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.
van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E
Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies to glomerular antigens.
Ronco P; Sahali D; Cittanova ML; van Leer EH; Chatelet F; Verroust P
Nephrol Dial Transplant; 1992; 7 Suppl 1():9-15. PubMed ID: 1362802
[No Abstract] [Full Text] [Related]
3. Molecular aspects of immune deposit formation in Heymann nephritis.
Kerjaschki D
Nephrol Dial Transplant; 1992; 7 Suppl 1():16-20. PubMed ID: 1283449
[No Abstract] [Full Text] [Related]
4. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
[TBL] [Abstract][Full Text] [Related]
5. Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV.
Natori Y; Hayakawa I; Shibata S
Clin Exp Immunol; 1987 Nov; 70(2):434-9. PubMed ID: 2892601
[TBL] [Abstract][Full Text] [Related]
6. Loss of antigens associated with the apical endocytotic pathway in proximal tubules from rats with heymann nephritis.
Gutmann EJ; Niles JL; McCluskey RT; Brown D
Am J Pathol; 1991 May; 138(5):1243-55. PubMed ID: 1708948
[TBL] [Abstract][Full Text] [Related]
7. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of cytoplasmic tail-containing form of gp600/megalin in active Heymann nephritis.
Oleinikov AV; Makker SP
J Pathol; 2000 Oct; 192(2):251-6. PubMed ID: 11004703
[TBL] [Abstract][Full Text] [Related]
9. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
Lab Invest; 1989 Jan; 60(1):138-46. PubMed ID: 2642986
[TBL] [Abstract][Full Text] [Related]
10. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis.
Miettinen A; Törnroth T; Ekblom P; Virtanen I; Linder E
Lab Invest; 1984 Apr; 50(4):435-46. PubMed ID: 6708453
[TBL] [Abstract][Full Text] [Related]
11. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T
Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
[TBL] [Abstract][Full Text] [Related]
12. Pathogenetic concepts of membranous glomerulopathy (MGN).
Kerjaschki D
J Nephrol; 2000; 13 Suppl 3():S96-100. PubMed ID: 11132040
[TBL] [Abstract][Full Text] [Related]
13. [The duality of Heymann nephritis antigen and immunogenoside--a minute quantity of a membranous nephritis-causing substance contained in somewhat crude nephritogenoside].
Shibata S
Arerugi; 1988 Jul; 37(7):397-403. PubMed ID: 3063233
[No Abstract] [Full Text] [Related]
14. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
[TBL] [Abstract][Full Text] [Related]
15. Studies of experimental membranous nephropathy.
Couser WG; Salant DJ; Adler S; Madaio MP
Transplant Proc; 1982 Sep; 14(3):474-81. PubMed ID: 6217598
[No Abstract] [Full Text] [Related]
16. Megalin/GP330 and pathogenetic concepts of membranous glomerulopathy (MGN).
Kerjaschki D
Kidney Blood Press Res; 2000; 23(3-5):163-6. PubMed ID: 11031710
[No Abstract] [Full Text] [Related]
17. Membranous nephropathy. Insights from Heymann nephritis.
Cavallo T
Am J Pathol; 1994 Apr; 144(4):651-8. PubMed ID: 8160766
[No Abstract] [Full Text] [Related]
18. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
[TBL] [Abstract][Full Text] [Related]
19. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
[TBL] [Abstract][Full Text] [Related]
20. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
Kerjaschki D
Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
